Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.32−0.10 (-7.04%)
Close on Nov 12, 2026Market cap $83.70MP/E –Yield –
Equillium total assets
Total assets on the balance sheet at the end of each period.
Equillium's total assets was $55.81M at Sep 30, 2026. For fiscal 2025 it was $31.89M, up 24.5% from the year before. The highest annual figure on record is $85.43M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.89M | +24.5% |
| FY2024 | Dec 31, 2024 | $25.60M | -49.3% |
| FY2023 | Dec 31, 2023 | $50.53M | -35.6% |
| FY2022 | Dec 31, 2022 | $78.42M | -8.2% |
| FY2021 | Dec 31, 2021 | $85.41M | -0.0% |
| FY2020 | Dec 31, 2020 | $85.43M | +53.8% |
| FY2019 | Dec 31, 2019 | $55.54M | -17.3% |
| FY2018 | Dec 31, 2018 | $67.16M | +839.2% |
| FY2017 | Dec 31, 2017 | $7.15M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $55.81M | +61.7% |
| Q2 FY2026 | Jun 30, 2026 | $58.67M | +373.2% |
| Q1 FY2026 | Mar 31, 2026 | $63.08M | +277.1% |
| Q4 FY2025 | Dec 31, 2025 | $31.89M | +24.5% |
| Q3 FY2025 | Sep 30, 2025 | $34.51M | +0.1% |
| Q2 FY2025 | Jun 30, 2025 | $12.40M | -71.1% |
| Q1 FY2025 | Mar 31, 2025 | $16.73M | -61.6% |
| Q4 FY2024 | Dec 31, 2024 | $25.60M | -49.3% |
| Q3 FY2024 | Sep 30, 2024 | $34.46M | -37.6% |
| Q2 FY2024 | Jun 30, 2024 | $42.86M | -27.1% |
| Q1 FY2024 | Mar 31, 2024 | $43.60M | -39.3% |
| Q4 FY2023 | Dec 31, 2023 | $50.53M | -35.6% |
| Q3 FY2023 | Sep 30, 2023 | $55.23M | +13.6% |
| Q2 FY2023 | Jun 30, 2023 | $58.76M | -5.9% |
| Q1 FY2023 | Mar 31, 2023 | $71.79M | -3.3% |
| Q4 FY2022 | Dec 31, 2022 | $78.42M | -8.2% |
| Q3 FY2022 | Sep 30, 2022 | $48.63M | -47.4% |
| Q2 FY2022 | Jun 30, 2022 | $62.47M | -37.4% |
| Q1 FY2022 | Mar 31, 2022 | $74.24M | -30.5% |
| Q4 FY2021 | Dec 31, 2021 | $85.41M | -0.0% |
| Q3 FY2021 | Sep 30, 2021 | $92.47M | +0.1% |
| Q2 FY2021 | Jun 30, 2021 | $99.84M | +125.6% |
| Q1 FY2021 | Mar 31, 2021 | $106.84M | +114.1% |
| Q4 FY2020 | Dec 31, 2020 | $85.43M | +53.8% |
| Q3 FY2020 | Sep 30, 2020 | $92.39M | +46.7% |
| Q2 FY2020 | Jun 30, 2020 | $44.26M | -23.5% |
| Q1 FY2020 | Mar 31, 2020 | $49.91M | -20.4% |
| Q4 FY2019 | Dec 31, 2019 | $55.54M | -17.3% |
| Q3 FY2019 | Sep 30, 2019 | $63.00M | +881.0% |
| Q2 FY2019 | Jun 30, 2019 | $57.89M | +709.5% |
| Q1 FY2019 | Mar 31, 2019 | $62.73M | – |
| Q4 FY2018 | Dec 31, 2018 | $67.16M | – |
| Q3 FY2018 | Sep 30, 2018 | $6.42M | – |
| Q4 FY2017 | Dec 31, 2017 | $7.15M | – |
See a number that looks wrong?